tirzepatide obesity fda grants fast track designation to tirzepatide, Eli Lilly's new type 2 diabetes drug, for treating FDA Grants Tirzepatide a New

Ozempic is FDA-approved to improve blood sugar control in adults with type 2 diabetes along with diet and exercise

The glucagon arm increases energy expenditure the number of calories the body burns at rest and accelerates hepatic (liver) lipid breakdown

Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying competition with its Danish rival Novo Nordisk in the key Asian market

Simonsen et al used the Norwegian and Danish national health registries and found an increased risk of NAION development with semaglutide initiation (HR = 2.81)

PMID 33053716